Dr Elizabeth Ursell is our Technical Director of Pharmacovigilance, having joined the business as Director for Advanced Therapies. A medicine safety professional with over 15 years of experience leading strategic safety projects and programmes in development and marketed drug portfolios. She has led safety strategy and provided input into development programs resulting in 30 submissions of which 30 were approved (10 CTAs, 20 MAs). She has also fulfilled the role of EEA QPPV for over 10 years for multiple companies and products. Elizabeth has broad therapeutic experience including specialty and primary care products in respiratory, oncology, inflammation, infectious diseases, gene therapy, cardiology, neurology and gastroenterology areas.
She is a trusted collaborator who enjoys leading projects and teams. Enjoys complexity and problem solving within the framework of an ever-evolving regulatory system, the core principle is to deliver the right drug to the right patients while ensuring their safety.